CLINICAL_TRIALS
trial_result
· 2022-10-17
Clinical Trial Update: Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma [Phase 1]
Summary
Phase 1 trial updating results for tezepelumab (AMG 157) in adults with mild asthma; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2022-10-17